| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 707.83B | 768.24B | 755.65B | 720.27B | 685.64B |
| Gross Profit | 78.47B | 92.60B | 94.53B | 85.28B | 85.85B |
| EBITDA | 40.29B | 50.34B | 72.40B | 66.89B | 58.52B |
| Net Income | 14.61B | 23.85B | 24.73B | 20.23B | 17.99B |
Balance Sheet | |||||
| Total Assets | 2.02T | 1.86T | 1.68T | 1.51T | 1.39T |
| Cash, Cash Equivalents and Short-Term Investments | 151.75B | 137.19B | 114.65B | 109.18B | 106.50B |
| Total Debt | 717.93B | 614.40B | 529.40B | 471.51B | 428.14B |
| Total Liabilities | 1.55T | 1.39T | 1.23T | 1.09T | 999.48B |
| Stockholders Equity | 294.78B | 313.43B | 301.73B | 281.98B | 260.35B |
Cash Flow | |||||
| Free Cash Flow | -17.22B | -1.63B | -26.85B | -33.59B | -49.60B |
| Operating Cash Flow | -3.72B | 12.51B | 12.07B | 442.29M | -12.64B |
| Investing Cash Flow | -51.16B | -29.62B | -55.88B | -46.68B | -52.82B |
| Financing Cash Flow | 63.86B | 41.64B | 50.33B | 52.86B | 42.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$47.91B | 4.99 | 11.89% | 6.69% | -5.48% | -4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$27.64B | 17.27 | 5.62% | 5.31% | 9.27% | -27.28% | |
57 Neutral | HK$81.57B | 8.64 | 5.22% | 3.90% | 5.40% | -33.06% | |
57 Neutral | HK$64.50B | 4.48 | 0.95% | 3.21% | -17.50% | -75.50% | |
53 Neutral | HK$114.72B | 5.07 | 7.18% | 6.36% | -5.33% | -38.33% | |
52 Neutral | HK$19.50B | 22.20 | 6.68% | ― | -3.56% | 49.92% |